Letter by Ng et al Regarding Article, “Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial” | Zendy

AI Assistant Blog Pricing

Letter by Ng et al Regarding Article, “Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial”

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.